- Home
- KROS vs VLGEA Comparison
KROS vs VLGEA Comparison
Compare KROS & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- VLGEA
- Stock Information
- Founded
- KROS 2015
- VLGEA 1937
- Country
- KROS United States
- VLGEA United States
- Employees
- KROS N/A
- VLGEA N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- VLGEA Food Chains
- Sector
- KROS Health Care
- VLGEA Consumer Staples
- Exchange
- KROS Nasdaq
- VLGEA Nasdaq
- Market Cap
- KROS 460.6M
- VLGEA 504.7M
- IPO Year
- KROS 2020
- VLGEA N/A
- Fundamental
- Price
- KROS $11.03
- VLGEA $34.38
- Analyst Decision
- KROS Buy
- VLGEA
- Analyst Count
- KROS 11
- VLGEA 0
- Target Price
- KROS $45.33
- VLGEA N/A
- AVG Volume (30 Days)
- KROS 2.1M
- VLGEA 30.6K
- Earning Date
- KROS 02-26-2025
- VLGEA 03-04-2025
- Dividend Yield
- KROS N/A
- VLGEA 2.94%
- EPS Growth
- KROS N/A
- VLGEA 2.47
- EPS
- KROS N/A
- VLGEA 3.48
- Revenue
- KROS $651,000.00
- VLGEA $2,257,909,000.00
- Revenue This Year
- KROS $303.27
- VLGEA N/A
- Revenue Next Year
- KROS N/A
- VLGEA N/A
- P/E Ratio
- KROS N/A
- VLGEA $9.80
- Revenue Growth
- KROS 8037.50
- VLGEA 3.42
- 52 Week Low
- KROS $9.78
- VLGEA $24.57
- 52 Week High
- KROS $73.00
- VLGEA $34.69
- Technical
- Relative Strength Index (RSI)
- KROS 25.01
- VLGEA 64.72
- Support Level
- KROS $11.04
- VLGEA $33.13
- Resistance Level
- KROS $11.36
- VLGEA $34.69
- Average True Range (ATR)
- KROS 0.53
- VLGEA 0.72
- MACD
- KROS 1.15
- VLGEA 0.17
- Stochastic Oscillator
- KROS 37.80
- VLGEA 89.27
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.